Selskabets formål er at drive virksomhed med forskning og udarbejdelse af stoffer, herunder til medicinalindustrien, samt enhver i forbindelse hermed stående virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | -27.9 mio. | -32.3 mio. | 39.4 mio. | 35.4 mio. | 36 | |
CVR: 36899069
Previous names: NMD Pharma ApS
Compared to 994 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Anja Ulrike Harmeier joined the board
David William Evans left the board
registered with 10% ownership
registered with 33% ownership
Companies in the same industry and area
CVR 26119898
CVR 45124606
CVR 44629399
CVR 40394591
CVR 44434903
companydata.dk